Biotech Lock-Up Expiration Hell Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (634)	2/19/2002 12:54:57 PM
From: tuck	Read Replies (1) of 1005

BLUE HP has noted a bit of insider buying in BDAL at the end of December in the high $14s. Mass spec sales have been strong at other companies. BDAL reports this Friday. BLUE HP will gamble most of its remaining cash that the insiders saw a nice finish towards the end of the quarter, that the number will be equal to or better than the expected 2 cents. BLUE HP, mirroring its manager, nibbles 200 shares at $11.93, the current ask. Still busy through this evening, but going to listen to the CIPH conference call soon, and report in the next couple of days. There has been some discussion on that thread following its announcement of study results concerning multiple biomarkers for ovarian cancer, which were analyzed with CIPH's chips. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next